Trial intelligence / Profile preview

LAICA trial of intermittent long-term levosimendan in advanced heart failure

2009-011441-11Phase 4Terminated

Sponsor
Hospital Universitario de Canarias
Start
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in heart failure (HF) comparing Simdax with Placebo (2 arms). Primary endpoints: Incidence of admission or hospitalization for worsening or decompensation of heart failure and Time from randomization to first hospitalization for heart failure decompensation. Started Jun 2009; status: terminated.

02

Drugs

levosimendan
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on 2009-011441-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011441-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call